Section edited by Sarah Warren
Molecular pathology has existed as a discipline for centuries, though without the modern name. Accumulating scientific insights, along with novel technological advances, are leading to greater understanding of the underlying causes of disease and novel diagnostic assays to inform clinical care. This section will serve as a platform to highlight studies that characterize human-derived biological materials, including both tissue and liquid biopsies, using molecular profiling techniques to elucidate the underlying causes of disease and impacts of therapeutic interventions.
We expect the section to appeal to scientists working on transcriptomics, proteomics, lipidomics, glycomics and beyond. Furthermore, we anticipate most studies in this section will be preclinical or translational in nature, although we will consider works from all stages of fundamental and applied research. We also welcome manuscripts that describe new technology platforms that advance molecular profiling or novel computational approaches to support data analysis.
